Skip to content
Lower risk Drug recall · FDA · Published June 1, 2026

Sandoz Focalin XR 5mg Capsules: Missing Lot/Exp Date Recall

Sandoz recalls Focalin XR 5mg capsules due to missing lot and expiration dates. Affected units may pose safety risks if not properly labeled.

🇺🇸 FDA recall #D-0608-2026DrugSandoz ›
Take action

Contact the company

Recalling firmSandoz Inc100 College Rd W · Princeton, NJ 08540-6604
✎ GovInfoNow plain-language explainer

Sandoz is recalling Focalin XR 5mg capsules because they may have missing or incorrect lot and expiration dates. This could lead to safety issues if the medication is not properly labeled. Read more at govinfonow.com/recall/31248-sandoz-focalin-xr-5mg-capsules-missing-lot-exp-date-recall.

Source Summary by GovInfoNow · govinfonow.com/recall/31248-sandoz-focalin-xr-5mg-capsules-missing-lot-exp-date-recall · Updated August 10, 2026 · FDA enforcement record: FDA #D-0608-2026

Cite this page

“Sandoz Focalin XR 5mg Capsules: Missing Lot/Exp Date Recall.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/31248-sandoz-focalin-xr-5mg-capsules-missing-lot-exp-date-recall. Based on FDA recall #D-0608-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0608-2026%22&limit=1).

The FDA announced on June 1, 2026, that Sandoz Inc is recalling Focalin XR (dexmethylphenidate HCl) 5 mg extended-release capsules due to incorrect or missing lot and expiration dates on the labeling. The recall affects 7,803 bottles distributed nationwide.

How to tell if you have it

  • Brand: Sandoz
  • Product: Focalin XR (dexmethylphenidate HCl) 5 mg, 30 extended-release capsules per bottle
  • NDC: 66758-235-31
  • Lot: VA0099422
  • Exp. Date: June 30, 2028
  • Manufacturer: Societal CDMO Gainesville, LLC, Gainesville, GA 30504

The hazard

The recall is due to labeling errors where the lot number and/or expiration date are incorrect or missing. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Sandoz Inc has issued 29 other recalls since October 9, 2013. Recent Sandoz recalls include a September 5, 2025 Cyclophosphamide Injection recall for temperature excursion risk and an August 13, 2025 Ciprofloxacin Otic Suspension recall for temperature abuse risk. Other recent recalls of similar products include Haleon Parodontax Mouthwash Recall (December 26, 2025), American Regent Levocarnitine Injection Recall (April 16, 2026), and Kirkman Lidocaine Cream Recall (February 18, 2026).

How to tell if you have this one

Check for the NDC code 66758-235-31 on the product label. The lot number should be VA0099422 and the expiration date June 30, 2028.

  • Brand
    Sandoz
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Label Details

    Verify the lot number (VA0099422) and expiration date (June 30, 2028) on the product label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 23 days after the firm started it.

1. Firm started the recall: Jun 1, 202612. FDA classified it Class III: Jun 22, 202623. Published in FDA’s Enforcement Report: Jun 24, 202632026
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0608-2026 (June 1, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0608-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA